Annual SGA
$5.01 M
-$670.10 K-11.81%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual SGA is $5.01 million, with the most recent change of -$670.10 thousand (-11.81%) on December 31, 2023.
- During the last 3 years, TENX annual SGA has fallen by -$302.10 thousand (-5.69%).
- TENX annual SGA is now -63.66% below its all-time high of $13.77 million, reached on April 30, 2014.
Performance
TENX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.51 M
+$162.40 K+12.08%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly SGA is $1.51 million, with the most recent change of +$162.40 thousand (+12.08%) on September 30, 2024.
- Over the past year, TENX quarterly SGA has increased by +$274.10 thousand (+22.24%).
- TENX quarterly SGA is now -84.80% below its all-time high of $9.91 million, reached on April 30, 2014.
Performance
TENX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.21 B
-$14.56 M-1.22%
September 30, 2024
Summary
- As of February 8, 2025, TENX TTM SGA is -$1.21 billion, with the most recent change of -$14.56 million (-1.22%) on September 30, 2024.
- Over the past year, TENX TTM SGA has dropped by -$1.22 billion (-24505.62%).
- TENX TTM SGA is now -11329.43% below its all-time high of -$10.60 million.
Performance
TENX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TENX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.8% | +22.2% | -10000.0% |
| 3 y3 years | -5.7% | +45.1% | -10000.0% |
| 5 y5 years | -11.5% | +45.1% | -10000.0% |
TENX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.0% | at low | -34.4% | +45.1% | -10.6% | at low |
| 5 y | 5-year | -34.0% | at low | -42.9% | +73.3% | -30.3% | at low |
| alltime | all time | -63.7% | +627.9% | -84.8% | +1406.8% | <-9999.0% | at low |
Tenax Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.51 M(+12.1%) | $5.73 M(+8.6%) |
| Jun 2024 | - | $1.34 M(+9.1%) | $5.27 M(+6.2%) |
| Mar 2024 | - | $1.23 M(-24.9%) | $4.96 M(-0.8%) |
| Dec 2023 | $5.01 M(-11.8%) | $1.64 M(+56.1%) | $5.01 M(+4.6%) |
| Sep 2023 | - | $1.05 M(+1.3%) | $4.78 M(-6.4%) |
| Jun 2023 | - | $1.04 M(-18.5%) | $5.11 M(-5.5%) |
| Mar 2023 | - | $1.27 M(-10.3%) | $5.41 M(-4.7%) |
| Dec 2022 | $5.68 M(-25.1%) | $1.42 M(+3.1%) | $5.68 M(-13.4%) |
| Sep 2022 | - | $1.38 M(+3.0%) | $6.55 M(-16.2%) |
| Jun 2022 | - | $1.34 M(-13.2%) | $7.81 M(+0.9%) |
| Mar 2022 | - | $1.54 M(-32.9%) | $7.75 M(+2.2%) |
| Dec 2021 | $7.58 M(+42.8%) | $2.30 M(-13.0%) | $7.58 M(+4.9%) |
| Sep 2021 | - | $2.64 M(+107.7%) | $7.23 M(+25.5%) |
| Jun 2021 | - | $1.27 M(-7.4%) | $5.76 M(+7.5%) |
| Mar 2021 | - | $1.37 M(-29.3%) | $5.36 M(+1.0%) |
| Dec 2020 | $5.31 M(+4.4%) | $1.94 M(+65.6%) | $5.31 M(+11.6%) |
| Sep 2020 | - | $1.17 M(+34.9%) | $4.76 M(-3.5%) |
| Jun 2020 | - | $869.20 K(-34.3%) | $4.93 M(-5.8%) |
| Mar 2020 | - | $1.32 M(-4.9%) | $5.23 M(+2.8%) |
| Dec 2019 | $5.08 M(-10.1%) | $1.39 M(+3.6%) | $5.08 M(-6.1%) |
| Sep 2019 | - | $1.34 M(+14.8%) | $5.41 M(+2.9%) |
| Jun 2019 | - | $1.17 M(-0.7%) | $5.26 M(-7.2%) |
| Mar 2019 | - | $1.18 M(-31.5%) | $5.67 M(+0.3%) |
| Dec 2018 | $5.65 M(-0.4%) | $1.72 M(+44.4%) | $5.65 M(+6.3%) |
| Sep 2018 | - | $1.19 M(-24.5%) | $5.32 M(+2.6%) |
| Jun 2018 | - | $1.58 M(+35.5%) | $5.18 M(-3.9%) |
| Mar 2018 | - | $1.16 M(-15.8%) | $5.39 M(-5.0%) |
| Dec 2017 | $5.68 M(-9.1%) | $1.38 M(+30.9%) | $5.67 M(-9.6%) |
| Sep 2017 | - | $1.06 M(-40.9%) | $6.28 M(-3.2%) |
| Jun 2017 | - | $1.79 M(+23.6%) | $6.48 M(+9.2%) |
| Mar 2017 | - | $1.45 M(-27.3%) | $5.94 M(-5.0%) |
| Dec 2016 | $6.25 M(+58.5%) | $1.99 M(+57.5%) | $6.25 M(+46.6%) |
| Sep 2016 | - | $1.26 M(+1.9%) | $4.26 M(-21.4%) |
| Jun 2016 | - | $1.24 M(-29.6%) | $5.43 M(-2.3%) |
| Mar 2016 | - | $1.76 M(+76.1%) | $5.56 M(-43.8%) |
| Dec 2015 | $3.94 M(-45.0%) | - | - |
| Oct 2015 | - | $1.00 M(-29.8%) | $9.89 M(+11.2%) |
| Sep 2015 | - | $1.43 M(+4.1%) | $8.89 M(+0.3%) |
| Jul 2015 | - | $1.37 M(-51.4%) | $8.86 M(-0.9%) |
| Apr 2015 | $7.17 M(-47.9%) | $2.82 M(+74.0%) | $8.94 M(+46.0%) |
| Mar 2015 | - | $1.62 M(-2.8%) | $6.13 M(-57.5%) |
| Jan 2015 | - | $1.66 M(+19.4%) | $14.42 M(-0.1%) |
| Oct 2014 | - | $1.39 M(-3.8%) | $14.43 M(-0.2%) |
| Jul 2014 | - | $1.45 M(-85.4%) | $14.45 M(+3.3%) |
| Apr 2014 | $13.77 M(+274.7%) | $9.91 M(+492.7%) | $13.99 M(+202.4%) |
| Jan 2014 | - | $1.67 M(+17.6%) | $4.63 M(+5.2%) |
| Oct 2013 | - | $1.42 M(+44.7%) | $4.39 M(+29.4%) |
| Jul 2013 | - | $982.50 K(+79.0%) | $3.40 M(-7.6%) |
| Apr 2013 | $3.68 M(-39.7%) | $549.00 K(-61.9%) | $3.68 M(-15.2%) |
| Jan 2013 | - | $1.44 M(+240.9%) | $4.33 M(+0.4%) |
| Oct 2012 | - | $422.80 K(-66.5%) | $4.32 M(-22.3%) |
| Jul 2012 | - | $1.26 M(+4.5%) | $5.55 M(-8.8%) |
| Apr 2012 | $6.09 M | $1.21 M(-15.1%) | $6.09 M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2012 | - | $1.42 M(-14.4%) | $6.89 M(-11.1%) |
| Oct 2011 | - | $1.66 M(-7.8%) | $7.75 M(+2.0%) |
| Jul 2011 | - | $1.80 M(-10.2%) | $7.60 M(-1.1%) |
| Apr 2011 | $7.68 M(+6.2%) | $2.00 M(-12.2%) | $7.68 M(+3.3%) |
| Jan 2011 | - | $2.28 M(+51.1%) | $7.43 M(+7.7%) |
| Oct 2010 | - | $1.51 M(-19.7%) | $6.90 M(-8.9%) |
| Jul 2010 | - | $1.88 M(+7.2%) | $7.58 M(+1.9%) |
| Apr 2010 | $7.24 M(+3.3%) | $1.76 M(+0.1%) | $7.44 M(+3.0%) |
| Jan 2010 | - | $1.75 M(-19.8%) | $7.22 M(+20.5%) |
| Oct 2009 | - | $2.19 M(+25.2%) | $5.99 M(+1.1%) |
| Jul 2009 | - | $1.75 M(+13.3%) | $5.93 M(-15.3%) |
| Apr 2009 | $7.00 M(+251.4%) | $1.54 M(+194.2%) | $7.00 M(+8.9%) |
| Jan 2009 | - | $523.50 K(-75.3%) | $6.43 M(-1.7%) |
| Oct 2008 | - | $2.12 M(-24.8%) | $6.54 M(+42.2%) |
| Jul 2008 | - | $2.82 M(+192.2%) | $4.60 M(+130.7%) |
| Apr 2008 | $1.99 M(+95.4%) | $964.70 K(+51.7%) | $1.99 M(+62.2%) |
| Jan 2008 | - | $635.90 K(+256.0%) | $1.23 M(+34.6%) |
| Oct 2007 | - | $178.60 K(-16.3%) | $912.90 K(-3.8%) |
| Jul 2007 | - | $213.50 K(+6.3%) | $948.70 K(-7.0%) |
| Apr 2007 | $1.02 M(-20.0%) | $200.80 K(-37.3%) | $1.02 M(-6.3%) |
| Jan 2007 | - | $320.00 K(+49.3%) | $1.09 M(-1.2%) |
| Oct 2006 | - | $214.40 K(-24.6%) | $1.10 M(-14.1%) |
| Jul 2006 | - | $284.50 K(+5.7%) | $1.28 M(+0.7%) |
| Apr 2006 | $1.27 M(-9.5%) | $269.10 K(-19.3%) | $1.27 M(-0.3%) |
| Jan 2006 | - | $333.60 K(-15.7%) | $1.28 M(-16.6%) |
| Oct 2005 | - | $395.70 K(+43.5%) | $1.53 M(+7.3%) |
| Jul 2005 | - | $275.70 K(+1.2%) | $1.43 M(+1.4%) |
| Apr 2005 | $1.41 M(+40.6%) | $272.30 K(-53.7%) | $1.41 M(+1.0%) |
| Jan 2005 | - | $588.30 K(+102.0%) | $1.39 M(+24.5%) |
| Oct 2004 | - | $291.30 K(+14.0%) | $1.12 M(+8.7%) |
| Jul 2004 | - | $255.60 K(-1.1%) | $1.03 M(+2.9%) |
| Apr 2004 | $1.00 M(+19.1%) | $258.40 K(-17.7%) | $1.00 M(+10.1%) |
| Jan 2004 | - | $314.00 K(+55.4%) | $909.20 K(+10.1%) |
| Oct 2003 | - | $202.00 K(-10.7%) | $825.60 K(-0.0%) |
| Jul 2003 | - | $226.30 K(+35.6%) | $826.00 K(-1.7%) |
| Apr 2003 | $840.40 K(-63.3%) | $166.90 K(-27.6%) | $840.30 K(-64.1%) |
| Jan 2003 | - | $230.40 K(+13.8%) | $2.34 M(+2.5%) |
| Oct 2002 | - | $202.40 K(-15.9%) | $2.28 M(-0.2%) |
| Jul 2002 | - | $240.60 K(-85.6%) | $2.29 M(-0.2%) |
| Apr 2002 | $2.29 M(+87.8%) | $1.67 M(+867.3%) | $2.29 M(+146.7%) |
| Jan 2002 | - | $172.40 K(-16.4%) | $929.10 K(-8.4%) |
| Oct 2001 | - | $206.30 K(-16.1%) | $1.01 M(-17.7%) |
| Jul 2001 | - | $246.00 K(-19.2%) | $1.23 M(+1.5%) |
| Apr 2001 | $1.22 M(+77.4%) | $304.40 K(+18.4%) | $1.21 M(+10.7%) |
| Jan 2001 | - | $257.20 K(-39.4%) | $1.10 M(+16.7%) |
| Oct 2000 | - | $424.30 K(+86.7%) | $939.20 K(+31.4%) |
| Jul 2000 | - | $227.30 K(+21.2%) | $714.90 K(+46.6%) |
| Apr 2000 | $687.60 K(-1.8%) | $187.60 K(+87.6%) | $487.60 K(+62.5%) |
| Jan 2000 | - | $100.00 K(-50.0%) | $300.00 K(+50.0%) |
| Oct 1999 | - | $200.00 K | $200.00 K |
| Apr 1999 | $700.00 K(-33.7%) | - | - |
| Apr 1998 | $1.06 M(-26.6%) | - | - |
| Apr 1997 | $1.44 M(+1.0%) | - | - |
| Apr 1996 | $1.42 M | - | - |
FAQ
- What is Tenax Therapeutics annual SGA?
- What is the all time high annual SGA for Tenax Therapeutics?
- What is Tenax Therapeutics annual SGA year-on-year change?
- What is Tenax Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly SGA year-on-year change?
- What is Tenax Therapeutics TTM SGA?
- What is the all time high TTM SGA for Tenax Therapeutics?
- What is Tenax Therapeutics TTM SGA year-on-year change?
What is Tenax Therapeutics annual SGA?
The current annual SGA of TENX is $5.01 M
What is the all time high annual SGA for Tenax Therapeutics?
Tenax Therapeutics all-time high annual SGA is $13.77 M
What is Tenax Therapeutics annual SGA year-on-year change?
Over the past year, TENX annual SGA has changed by -$670.10 K (-11.81%)
What is Tenax Therapeutics quarterly SGA?
The current quarterly SGA of TENX is $1.51 M
What is the all time high quarterly SGA for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly SGA is $9.91 M
What is Tenax Therapeutics quarterly SGA year-on-year change?
Over the past year, TENX quarterly SGA has changed by +$274.10 K (+22.24%)
What is Tenax Therapeutics TTM SGA?
The current TTM SGA of TENX is -$1.21 B
What is the all time high TTM SGA for Tenax Therapeutics?
Tenax Therapeutics all-time high TTM SGA is -$10.60 M
What is Tenax Therapeutics TTM SGA year-on-year change?
Over the past year, TENX TTM SGA has changed by -$1.22 B (-24505.62%)